This is a paid press release. Contact the press release distributor directly with any inquiries.

Bio/Pharmaceutical Outsourcing Report December 2025: Trump Administration Sets Deadline for Pharma Companies to Fulfill MFN Commitments/UK-US Tariff Deal and Pricing Reforms Position UK As Global Hub

Research and Markets

Thu, February 19, 2026 at 1:26 AM GMT+9 5 min read

Company Logo

The report highlights opportunities in emerging trends and innovations in the pharmaceutical outsourcing sector, offering insights into new contracts and M&A deals. It advises on navigating regulatory changes, supply chain disruptions, and technology investments, guiding CMOs, procurement executives, and investors.

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) – The “Bio/Pharmaceutical Outsourcing Report, December 2025” report has been added to ** ResearchAndMarkets.com’s** offering.

The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs).

It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.

Report Scope

This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from the analyst’s experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for:

CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.

Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.

Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.

Reasons to Buy

Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.

Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.

Learn about the past quarter's M&A and financing deals in the manufacturing space.

Identify the latest contract service agreements.

Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.

Stay ahead of disruption with updates on supply chain obstacles and new regulations.

 






Story Continues  

Key Topics Covered:

Industry Trends

UK-US zero-tariff deal and pricing reforms position UK as global hub for innovative medicines

Trump administration sets deadline for pharma companies to fulfill MFN commitments

Industry Analysis

Contract service agreements

Contract manufacturing - opportunities and threats

Quarterly mergers, acquisitions, and financing - Q4 2025

Value Chain

Compounding

API chemical

API biologics - cell, gene, vaccine, and virus

API biologics (protein and peptide)

Commercial dose manufacturing and packaging

Clinical dose manufacturing

About the Analyst

Companies Featured

Advent Bioservices Ltd

AGC Biologics Inc

AGC Pharma Chemicals Europe SLU

Akadeum Life Sciences Inc

Alcami Corp

Almac Group Ltd

Alnylam Pharmaceuticals Inc

Alvogen Inc

Andelyn Biosciences Inc

Antheia Inc

Arthrosi Therapeutics Inc

AstraZeneca Pharmaceuticals LP

AstraZeneca Plc

AstraZeneca UK Ltd

Athlone Laboratories Ltd

ATUM

Astellas US LLC

A-Seeds Co Ltd

AAVantgarde Bio Srl

Avid Bioservices Inc

Bayer AG

Bayer USA LLC

Beigene USA Inc

BioCorRx Inc

BioCryst Pharmaceuticals Inc

BioLabs for Advanced Therapeutics Philadelphia

BioNTech

BioSpring GmbH

Boehringer Ingelheim Fremont Inc

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Pharma GmbH & Co KG

Boehringer Ingelheim Pharmaceuticals

Bora Pharmaceuticals Co Ltd

Brenntag SE

Bristol Myers Squibb

Catalent CTS LLC

Catalent Germany Eberbach GmbH

Catalent Inc

Cell and Gene Therapy Catapult

Cellergy Therapeutics Ltd

Cellipont Bioservices

Cell Therapies Pty Ltd

Charles River Laboratories International Inc

CStone Pharmaceuticals Co Ltd

Circurna

CStone Pharmaceuticals Co Ltd

CPC Scientific Inc

Corealis Pharma Inc

Coriolis Pharma Research GmbH

Curileum Discovery Ltd

Daiichi Sankyo Co Ltd

eXmoor Pharma Concepts Ltd

EMD Serono (US)

Eli Lilly (US)

Encell Co Ltd

Esteve Pharmaceuticals SA

Esteve Quimica SA

Fortrea Inc

FUJIFILM Cellular Dynamics Inc

Gaelic Laboratories Ltd

Gazyvaro

Genmab US Inc

Glenmark Pharmaceuticals Ltd

GRI Bio Operations Inc

GSK plc

Halo Pharma Inc

Hikma Pharmaceuticals Plc

Horizon Therapeutics USA Inc

IDT Biologika GmbH

Incyte Corp

INCOG BioPharma Services Inc

Infant Bacterial Therapeutics

Insmed Inc

Intrepid Labs

Ionetix Corp

IVERIC bio Inc

Jiangsu Jiaerke Pharmaceutical Group Co Ltd

Johnson & Johnson

Janssen Biotech Inc

Janssen-Cilag International

Kenai Therapeutics Inc

Lifecore Biomedical LLC

Lindus Health Ltd

Lotus US Financing

Lonza Group Ltd

Luxna Biotech Co Ltd

Merck & Co Inc

Merck Sharp & Dohme LLC

Mendus

Microsize

Minakem SAS

Moderna

NorthX Biologics Matfors AB

Novartis

Novartis Gene Therapies

Novo Nordisk AS

Organon & Co

PCI Pharma Services

PharmAla Biotech Holdings Inc

PharmaKorell GmbH

Pharmstandard

Pfizer Inc

Piramal Pharma Solutions Inc

Plasticell Ltd

ProBioGen AG

Quotient Sciences Ltd

Ratio Therapeutics Inc

Recipharm AB

Recordati UK Ltd

Rentschler Biopharma SE

Repair Biotechnologies Inc

Rinri Therapeutics Ltd

Roche

Ronawk Inc

Sanofi

Samsung Biologics Co Ltd

Sandoz GmbH

Schedio SA

Sharp Packaging Services LLC

Sistemic Ltd

SmartCella Holding

Societal CDMO Inc

StemSight Oy

Swedish Orphan Biovitrum

Syenex Inc

Telomir Pharmaceuticals Inc

TetraScience Inc

Thermo Fisher Scientific Inc

Tivic Health Systems Inc

Tjoapack BV

Turbare Manufacturing LLC

TUV SUD AG

UBriGene Biosciences Inc

Vicebio Ltd

Vetter Pharma-Fertigung GmbH & Co KG

WuXi Biologics Co Ltd

WuXi STA

WuXi XDC Cayman Inc

Xellera Therapeutics Ltd

Zhejiang Xianju Junye Pharmaceutical Co Ltd

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Terms and Privacy Policy

Privacy Dashboard

More Info